Press Release: Psyence Biomed Enters Into Agreement to Acquire Stake in PsyLabs
Press Release: Psyence Biomed Issues Shareholder Update Recapping Recent Progress and Previewing Key Upcoming Data Milestones
Express News | Psyence Biomedical Ltd - Biomed to Advance up to $1.8 Million to Clairvoyant
Press Release: Psyence Biomed Announces the Signing of a Conditional Binding Term Sheet for the Acquisition of Psilocybin-Based Drug Developer Clairvoyant
6-K: Report of foreign private issuer (related to financial reporting)
20-F: FY2024 Annual Report